Immunogenicity and Safety of V70P5 Revaccination Subjects

A Phase IIIB, Observer-Blind, Randomized, Parallel Groups, Extension Study to Evaluate the Immunogenicity and Safety Following a Single Intramuscular Dose of a Sub-unit Adjuvanted or a Non-adjuvanted Influenza Vaccines in Healthy Children Previously Vaccinated in the V70P5 Study

This study will evaluate the safety and immunogenicity of children previously primed in the V70P5 study when revaccinated with adjuvanted or unadjuvanted seasonal influenza vaccine.

Inclusion Criteria:

• Healthy male or female children that have previously participated in the V70P5 study in Finland.

Exclusion Criteria:

• Any condition which in the opinion of the investigator may interfere with the evaluation of the study objectives.